Connection

Alba Grifoni to Humans

Back to Details
This is a "connection" page, showing publications Alba Grifoni has written about Humans.
Alba Grifoni
Connection Strength
0.096
Humans
  1. SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19. Cell Host Microbe. 2021 07 14; 29(7):1076-1092.
    View in: PubMed
    Score: 0.008
  2. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020 06 25; 181(7):1489-1501.e15.
    View in: PubMed
    Score: 0.007
  3. A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2. Cell Host Microbe. 2020 04 08; 27(4):671-680.e2.
    View in: PubMed
    Score: 0.007
  4. A survey of known immune epitopes in the enteroviruses strains associated with acute flaccid myelitis. Hum Immunol. 2019 Nov; 80(11):923-929.
    View in: PubMed
    Score: 0.007
  5. Characterization of Magnitude and Antigen Specificity of HLA-DP, DQ, and DRB3/4/5 Restricted DENV-Specific CD4+ T Cell Responses. Front Immunol. 2019; 10:1568.
    View in: PubMed
    Score: 0.007
  6. Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus-Specific CD8+ T Cells. J Immunol. 2018 12 15; 201(12):3487-3491.
    View in: PubMed
    Score: 0.006
  7. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 159 individuals from the Worcester region of the Western Cape province of South Africa. Hum Immunol. 2018 Mar; 79(3):143-144.
    View in: PubMed
    Score: 0.006
  8. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 714 adults from Colombo, Sri Lanka. Hum Immunol. 2018 Feb; 79(2):87-88.
    View in: PubMed
    Score: 0.006
  9. Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2?30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain. J Virol. 2017 Apr 15; 91(8).
    View in: PubMed
    Score: 0.006
  10. Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination. Immunity. 2021 09 14; 54(9):2133-2142.e3.
    View in: PubMed
    Score: 0.002
  11. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers. J Infect Dis. 2021 07 02; 224(1):70-80.
    View in: PubMed
    Score: 0.002
  12. Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals. Cell Rep Med. 2021 07 20; 2(7):100355.
    View in: PubMed
    Score: 0.002
  13. Activation of mTORC1 at late endosomes misdirects T cell fate decision in older individuals. Sci Immunol. 2021 06 18; 6(60).
    View in: PubMed
    Score: 0.002
  14. Immune Memory in Mild COVID-19 Patients and Unexposed Donors Reveals Persistent T Cell Responses After SARS-CoV-2 Infection. Front Immunol. 2021; 12:636768.
    View in: PubMed
    Score: 0.002
  15. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S82-S87.
    View in: PubMed
    Score: 0.002
  16. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. J Infect. 2021 04; 82(4):58-66.
    View in: PubMed
    Score: 0.002
  17. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021 02 05; 371(6529).
    View in: PubMed
    Score: 0.002
  18. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19. Front Immunol. 2020; 11:596761.
    View in: PubMed
    Score: 0.002
  19. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):286.e7-286.e13.
    View in: PubMed
    Score: 0.002
  20. Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4+ T Cells in COVID-19. Cell. 2020 11 25; 183(5):1340-1353.e16.
    View in: PubMed
    Score: 0.002
  21. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell. 2020 11 12; 183(4):996-1012.e19.
    View in: PubMed
    Score: 0.002
  22. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020 10 02; 370(6512):89-94.
    View in: PubMed
    Score: 0.002
  23. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol. 2020 06 26; 5(48).
    View in: PubMed
    Score: 0.002
  24. Human T Cell Response to Dengue Virus Infection. Front Immunol. 2019; 10:2125.
    View in: PubMed
    Score: 0.002
  25. Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles. J Clin Invest. 2019 03 18; 129(4):1727-1741.
    View in: PubMed
    Score: 0.002
  26. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 496 adults from San Diego, California, USA. Hum Immunol. 2018 Dec; 79(12):821-822.
    View in: PubMed
    Score: 0.002
  27. Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL. PLoS Negl Trop Dis. 2017 12; 11(12):e0006000.
    View in: PubMed
    Score: 0.001
  28. Sequence-based HLA-A, B, C, DP, DQ, and DR typing of 339 adults from Managua, Nicaragua. Hum Immunol. 2018 Jan; 79(1):1-2.
    View in: PubMed
    Score: 0.001
  29. Development of a strategy and computational application to select candidate protein analogues with reduced HLA binding and immunogenicity. Immunology. 2018 01; 153(1):118-132.
    View in: PubMed
    Score: 0.001
  30. PD-1/PD-L1 expression in extra-medullary lesions of multiple myeloma. Leuk Res. 2016 10; 49:98-101.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.